Author:

Keywords:

Exclusion, familial hypercholesterolemia, Germany, Netherlands, public health genomics, United Kingdom, Genetics, Population, Genomics, Humans, Hyperlipidemia, Familial Combined, Public Health, Science & Technology, Life Sciences & Biomedicine, Public, Environmental & Occupational Health, GENETICS, DISEASE, Genetic Predisposition to Disease, Genetic Testing, 1117 Public Health and Health Services, 4202 Epidemiology, 4206 Public health

Abstract:

Considerable progress in public health is expected to occur from the application of genomic knowledge and technologies. This is the subject of a newly emerging field of public health genomics. In this paper we analyze differences in how public health genomics is developing in the Netherlands, the UK and Germany through the definition and diagnosis of familial hypercholesterolaemia (FH), an inherited predisposition for coronary heart disease.